StayCurrentMD · Journal of Pediatric Surgery Article Review: June 2023, AAP Issue
Follow
Video13 min·Published Jul 2026

Journal of Pediatric Surgery Article Review: June 2023, AAP Issue

With Dr. Colin Martin & Dr. Brad Warner & Dr. Andrew Fleming · hosted by Dr. Cecilia Gigena & Dr. M. Tom Bash & Dr. Todd Ponsky
Try
Intelligent Search· scoped to short bowel syndrome · not medical adviceSearch the whole library →
What the experts said6 expert statements · 8 host summaries
The ileocecal region may not be important to preserve in short bowel syndrome and may actually be injurious to the liver.
ClinicalBrad Warner
Administration of a specific bile acid that is more lipophilic and hepatoprotective could be potential therapy for patients with cholestatic liver disease after massive intestinal resection.
ClinicalBrad Warner
In clinical practice, surgeons cannot choose which segment of intestine to remove—they must remove what is dead and would never intentionally remove viable tissue.
ClinicalBrad Warner
Once no-evidence-of-disease status was achieved, the 10-year overall survival among high-risk hepatoblastoma patients was similar to patients who were not high-risk.
EpidemiologicalAndrew Fleming
There is no threshold for disease burden that precludes aggressive pursuit of no-evidence-of-disease status in children with hepatoblastoma.
OpinionAndrew Fleming
The way to achieve esophageal atresia surveillance is to have a formal aerodigestive team.
OpinionTodd Ponsky
Proximal small bowel resection results in greater oxidative stress in the liver compared to distal resection, as evidenced by elevated messenger RNA transcripts for tumor necrosis factor alpha, NADPH oxidase, and glutathione synthase.
Host summaryColin Martin summarizing the discussion · not cited in answers
46 of 50 hepatoblastoma patients underwent resection using adjuvant techniques including total hepatic vascular exclusion, vascular reconstruction, biliary reconstruction, or en-bloc resection and total hepatectomy with transplantation.
Host summaryColin Martin summarizing the discussion · not cited in answers
82% of hepatoblastoma patients (41 out of 50) achieved no-evidence-of-disease status through aggressive surgical management.
Host summaryColin Martin summarizing the discussion · not cited in answers
14 high-risk hepatoblastoma patients underwent a median of 2.5 pulmonary metastasectomies (7 for unilateral disease, 7 for bilateral disease) with a median of 4.5 nodules resected.
Host summaryEm Tombash summarizing the discussion · not cited in answers
5 high-risk hepatoblastoma patients relapsed and 3 of them were saved.
Host summaryEm Tombash summarizing the discussion · not cited in answers
The esophageal atresia surveillance survey had a 77% response rate from 181 physicians at 19 institutions.
Host summaryColin Martin summarizing the discussion · not cited in answers
Only 36% of institutions perform routine upper GI endoscopy in esophageal atresia patients regardless of symptoms, despite evidence showing these patients should be surveilled.
Host summaryColin Martin summarizing the discussion · not cited in answers
Without proper surveillance, esophageal atresia patients are at risk for esophageal cancer and chronic dysmotility as they survive into adulthood.
Host summaryColin Martin summarizing the discussion · not cited in answers